Beef Powder Shows Unexpected Anti-Inflammatory Power Against Colitis in Mice

Red meat has spent the better part of a decade as one of nutrition science’s most polarizing villains, blamed for everything from cardiovascular disease to colorectal cancer. But a new study from researchers at Kangwon National University in South Korea is complicating that picture in a way few expected. In a carefully controlled mouse experiment published in Food Science of Animal Resources, a team led by Hye-Jin Kim and Aera Jang found that supplementing the diet with powdered lean beef—the round cut from Hanwoo cattle, Korea’s native beef breed—appeared to protect animals against chemically induced colitis, one of the most widely used laboratory models of inflammatory bowel disease. The effect was not dramatic, but it was measurable, statistically significant, and mechanistically coherent, and it points toward a more nuanced understanding of how meat, inflammation, and gut health interact.

The researchers worked with forty-eight male C57BL/6J mice, a standard laboratory strain, dividing them into four groups of twelve. One group served as a healthy control, eating ordinary rodent chow. A second group ate the same chow but received dextran sulfate sodium, or DSS, a sulfated polysaccharide added to drinking water that strips away the protective mucus layer of the colon and triggers a rapid, reproducible inflammatory injury. The remaining two groups received diets containing either 10 percent or 20 percent Hanwoo round beef powder for the full forty-two days of the experiment, with DSS introduced during the final week. The beef was cooked to an internal temperature of 75 degrees Celsius, freeze-dried, and blended into the feed, with the two supplementation levels corresponding to human equivalents of roughly 58 and 115 grams per day for a 60-kilogram adult.

The design matters because it tested prevention rather than treatment. The animals consumed beef for five weeks before any inflammatory challenge began, allowing the researchers to ask whether the meat could prime the gut to resist injury, not whether it could cure disease once established. That distinction shaped the results. Beef supplementation did not prevent the weight loss and reduced feed intake that DSS reliably produces; all colitis groups lost about 20 percent of their body weight during the induction week. But in the mice eating the higher dose of beef, several key indicators of colonic damage were noticeably blunted compared with the DSS-only animals.

The most striking macroscopic finding involved colon length. Inflammatory shortening of the colon is a hallmark of colitis severity, reflecting tissue contraction and scarring. The healthy controls had colons averaging 8.17 centimeters, while the DSS group’s colons shrank to 5.92 centimeters. In the mice fed 20 percent beef, colons averaged 6.42 centimeters—a statistically significant rescue of nearly half a centimeter. Histological examination reinforced the trend. Under the microscope, the DSS-only colons showed the expected devastation: epithelial erosion, widespread loss of the crypt structures that house stem cells, submucosal edema, and dense infiltration of immune cells. The beef-fed animals retained substantially more crypt architecture and showed less inflammatory infiltration, and the formal histological colitis score was significantly lower in the 20 percent beef group than in the DSS controls.

What makes the study more than a curiosity is the molecular work underneath. The team measured malondialdehyde, or MDA, a lipid peroxidation product that serves as a proxy for oxidative damage to cell membranes, alongside glutathione, or GSH, the colon’s principal endogenous antioxidant. DSS pushed these markers in the expected directions—MDA up, GSH down—but 20 percent beef supplementation significantly reversed both, lowering MDA and restoring GSH. Myeloperoxidase activity, an enzyme marker of neutrophil infiltration, rose in all colitis groups but did not differ among them, suggesting the beef was acting downstream of immune cell recruitment, on the chemistry of tissue damage itself rather than on the arrival of the cells.

The cytokine data told a complementary story. T helper lymphocytes orchestrate intestinal inflammation through two opposing arms: Th1 cytokines such as interleukin-6, interferon-gamma, and tumor necrosis factor-alpha drive inflammation, while Th2 cytokines like interleukin-5 and interleukin-10 restrain it. In the beef-supplemented colitis group, the pro-inflammatory Th1 cytokines in colonic tissue fell significantly, the anti-inflammatory IL-5 rose, and the overall Th1-to-Th2 ratio dropped from 1.09 in the DSS group to 0.63—a substantial shift in the immunological balance of the injured gut.

The clearest mechanistic signal, however, came from Western blot analysis of two inflammatory enzymes. Cyclooxygenase-2, or COX-2, is the inducible enzyme that produces prostaglandins at sites of inflammation, and it is a well-established drug target; COX-2 overexpression in the colon is also implicated in promoting tumor cell proliferation. DSS strongly upregulated COX-2 protein in colonic tissue, but beef supplementation suppressed it in a dose-dependent manner, with both the 10 and 20 percent diets producing significant reductions. Inducible nitric oxide synthase, or iNOS, another ROS-activated inflammatory enzyme, was upregulated by DSS but was not significantly affected by the beef diet—a selectivity that suggests the meat’s bioactive compounds were modulating a specific inflammatory pathway rather than globally dampening all inflammatory signaling.

The study also documented unexpected effects on lipid metabolism. DSS colitis raised serum triglycerides and LDL cholesterol while suppressing the fecal excretion of lipids, a pattern consistent with inflammation-driven disruption of cholesterol clearance. Beef supplementation lowered serum triglycerides and total cholesterol in the colitis animals and restored fecal lipid excretion, with the 20 percent group’s fecal cholesterol and LDL levels climbing back to nearly control levels. The authors connect this to the meat’s antioxidant capacity: their previous work found that Hanwoo beef extract has an oxygen radical absorbance capacity comparable to strawberries and black raspberries, and the meat is rich in L-carnitine—about 3.64 micromoles per gram of wet weight, far exceeding chicken or pork—which previous studies have linked to reduced oxidative stress markers in colitis models.

None of this means steak is medicine, and the researchers are careful about the limits of their findings. The DSS model reproduces acute epithelial injury but not the chronic, relapsing inflammation of human inflammatory bowel disease, and the protective effects observed were modest—beef did not rescue weight loss, feed intake, or the full disease activity index by the end of the experiment. The specific compounds responsible remain unidentified, though candidates include carnosine, coenzyme Q10, creatine, L-carnitine, and a novel antioxidant octapeptide the team previously isolated from Hanwoo round beef that showed antiproliferative activity against colorectal cancer cells. The authors also note that the doses used correspond to intake levels referenced in the epidemiological assessments behind the International Agency for Research on Cancer’s classification of red meat as probably carcinogenic—yet in this model, beef did not aggravate colitis and instead showed mild preventive tendencies.

Still, the study lands at a scientifically interesting moment. It joins a small but growing body of work suggesting that lean red meat, in controlled contexts and at moderate doses, contains bioactive compounds with genuine anti-inflammatory and antioxidant properties in the gut. The authors call for follow-up studies using higher supplementation levels, longer feeding periods, purified bioactive fractions, and chronic or milder colitis models to pin down the mechanisms and test whether the effects translate beyond acute chemical injury. Until then, the message is neither a green light for unlimited red meat nor a confirmation of its worst reputation, but something more interesting: the biology of meat and inflammation is far from settled, and even the most scrutinized foods in the human diet may still have surprises left in them.

Subject of Research: Effects of dietary beef powder supplementation on dextran sulfate sodium-induced colitis in mice via the COX-2 inflammatory pathway

Article Title: The effects of dietary beef powder on the dextran sulfate sodium-induced colitis in a mouse model through COX-2 pathway

Article References: Kim, H.-J., Kim, D., & Jang, A. (2026). The effects of dietary beef powder on the dextran sulfate sodium-induced colitis in a mouse model through COX-2 pathway. Food Science of Animal Resources, 46(1), Article 64. https://doi.org/10.1007/s44463-025-00054-5

Image Credits: AI Generated

DOI: 10.1007/s44463-025-00054-5

Keywords: colitis, inflammatory bowel disease, red meat, COX-2, oxidative stress, cytokines, mouse model, dextran sulfate sodium, nutrition, Hanwoo beef, glutathione, gut inflammation